Skip to main content
Top
Published in: Lung 1/2017

01-02-2017

The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes

Authors: Xingjian Liu, Shuren Ma, Gerard Turino, Jerome Cantor

Published in: Lung | Issue 1/2017

Login to get access

Abstract

Introduction

Desmosine and isodesmosine (DID) are unique elastin crosslinks that may serve as biomarkers for elastic fiber degradation in chronic obstructive pulmonary disease. Previously, our laboratory found that the ratio of free to peptide-bound DID in bronchoalveolar lavage fluid (BALF) showed a significant positive correlation with the extent of airspace enlargement in an elastase model of pulmonary emphysema. To further evaluate this hypothesis, our laboratory measured this ratio in a bleomycin (BLM) model of pulmonary fibrosis, which involved different microarchitectural changes than those associated with pulmonary emphysema.

Methods

Syrian hamsters were instilled intratracheally with 1.0 unit BLM in 0.2 ml of normal saline (controls received the vehicle alone), and BALF was analyzed for both free and total DID, using a combination of liquid chromatography and tandem mass spectrometry.

Results

Total BALF DID was significantly increased in hamsters receiving BLM at 1 week post-treatment (92 vs 13 pg/ml; p < 0.001), consistent with elastic fiber degradation. However, in contrast to elastase-induced emphysema, free/bound DID was lower in BLM-treated animals compared to controls at both 1 week (0.76 vs 0.84) and 2 weeks post-treatment (0.69 vs 0.86), though the differences were not statistically significant.

Conclusions

These results indicate that it may be possible to identify specific pulmonary microarchitecture changes, based on the ratio of free to peptide-bound DID. It is speculated that the proportionate decrease in free DID in BLM-induced fibrosis may be due to preservation of intact elastic fibers as the lung injury progresses.
Literature
1.
go back to reference Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4:435–459CrossRefPubMed Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4:435–459CrossRefPubMed
2.
4.
go back to reference Turino GM, Lin YY, He J et al (2012) Elastin degradation: an effective biomarker in COPD. COPD 9:435–438CrossRefPubMed Turino GM, Lin YY, He J et al (2012) Elastin degradation: an effective biomarker in COPD. COPD 9:435–438CrossRefPubMed
5.
go back to reference Lindberg CA, Engström G, de Verdier MG et al (2012) Total desmosines in plasma and urine correlate with lung function. Eur Respir J 39:839–845CrossRefPubMed Lindberg CA, Engström G, de Verdier MG et al (2012) Total desmosines in plasma and urine correlate with lung function. Eur Respir J 39:839–845CrossRefPubMed
6.
go back to reference Ma S, Turino GM, Lin YY (2011) Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. J Chromatogr B 879:1893–1898CrossRef Ma S, Turino GM, Lin YY (2011) Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. J Chromatogr B 879:1893–1898CrossRef
7.
go back to reference Fregonese L, Ferrari F, Fumagalli M et al (2011) Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD. COPD 8:329–333CrossRefPubMed Fregonese L, Ferrari F, Fumagalli M et al (2011) Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD. COPD 8:329–333CrossRefPubMed
8.
go back to reference Luisetti M, Ma S, Iadarola P et al (2008) Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 32:1146–1157CrossRefPubMed Luisetti M, Ma S, Iadarola P et al (2008) Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 32:1146–1157CrossRefPubMed
9.
go back to reference Ma S, Lin YY, Turino GM (2007) Measurements of desmosine and isodesmosine by mass spectrometry in COPD. Chest J 131:1363–1371CrossRef Ma S, Lin YY, Turino GM (2007) Measurements of desmosine and isodesmosine by mass spectrometry in COPD. Chest J 131:1363–1371CrossRef
10.
go back to reference Cantor JO, Ma SM, Turino GM (2013) What percolation theory can tell us about COPD. Med Hypotheses 81:152–155CrossRefPubMed Cantor JO, Ma SM, Turino GM (2013) What percolation theory can tell us about COPD. Med Hypotheses 81:152–155CrossRefPubMed
11.
go back to reference Liu X, Ma S, Liu S et al (2015) The ratio of free to bound desmosine and isodesmosine may reflect emphysematous changes in COPD. Lung 193:329–334CrossRefPubMed Liu X, Ma S, Liu S et al (2015) The ratio of free to bound desmosine and isodesmosine may reflect emphysematous changes in COPD. Lung 193:329–334CrossRefPubMed
12.
go back to reference Bunde A, Kantelhart JW (2005) Diffusion and conduction in percolation systems. In: Heitjans P, Karger J (eds) Diffusion in condensed matter. Springer, Berlin, pp 895–914CrossRef Bunde A, Kantelhart JW (2005) Diffusion and conduction in percolation systems. In: Heitjans P, Karger J (eds) Diffusion in condensed matter. Springer, Berlin, pp 895–914CrossRef
13.
go back to reference Redner S (2009) Fractal and multifractal scaling of electrical conduction in random resistor networks. In: Meyers PA (ed) Encyclopedia of complexity and systems science. Springer, Berlin, pp 3737–3754CrossRef Redner S (2009) Fractal and multifractal scaling of electrical conduction in random resistor networks. In: Meyers PA (ed) Encyclopedia of complexity and systems science. Springer, Berlin, pp 3737–3754CrossRef
14.
go back to reference Sander LM, Warren CP, Sokolov IM et al (2002) Percolation on heterogeneous networks as a model for epidemics. Math Biosci 180:293–305CrossRefPubMed Sander LM, Warren CP, Sokolov IM et al (2002) Percolation on heterogeneous networks as a model for epidemics. Math Biosci 180:293–305CrossRefPubMed
15.
go back to reference Sahimi M (2009) Percolation phase transition. In: Meyers PA (ed) Encyclopedia of complexity and systems science. Springer, Berlin, pp 6538–6545CrossRef Sahimi M (2009) Percolation phase transition. In: Meyers PA (ed) Encyclopedia of complexity and systems science. Springer, Berlin, pp 6538–6545CrossRef
16.
go back to reference Shah D, Romero F, Stafstrom W et al (2014) Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 306:L152–L161CrossRefPubMed Shah D, Romero F, Stafstrom W et al (2014) Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 306:L152–L161CrossRefPubMed
17.
go back to reference Li B, Daggett V (2002) Molecular basis for the extensibility of elastin. J Muscle Res Cell Motil 23:561–573CrossRefPubMed Li B, Daggett V (2002) Molecular basis for the extensibility of elastin. J Muscle Res Cell Motil 23:561–573CrossRefPubMed
18.
go back to reference Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115:2817–2828PubMed Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115:2817–2828PubMed
19.
go back to reference Murphy KD, Hunt GW, Almond DP (2006) Evidence of emergent scaling in mechanical systems. Philos Mag 86:3325–3338CrossRef Murphy KD, Hunt GW, Almond DP (2006) Evidence of emergent scaling in mechanical systems. Philos Mag 86:3325–3338CrossRef
20.
go back to reference Jesudason R, Black L, Majumdar A et al (2007) Differential effects of static and cyclic stretching during elastase digestion on the mechanical properties of extracellular matrices. J Appl Physiol 103:803–811CrossRefPubMed Jesudason R, Black L, Majumdar A et al (2007) Differential effects of static and cyclic stretching during elastase digestion on the mechanical properties of extracellular matrices. J Appl Physiol 103:803–811CrossRefPubMed
21.
go back to reference Nettelbladt O, Scheynius A, Bergh J et al (1991) Alveolar accumulation of hyaluronan and alveolar cellular response in bleomycin-induced alveolitis. Eur Respir J 4:407–414PubMed Nettelbladt O, Scheynius A, Bergh J et al (1991) Alveolar accumulation of hyaluronan and alveolar cellular response in bleomycin-induced alveolitis. Eur Respir J 4:407–414PubMed
22.
go back to reference Cantor JO, Turino GM (2004) Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema? Chest J 125:288–292CrossRef Cantor JO, Turino GM (2004) Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema? Chest J 125:288–292CrossRef
23.
go back to reference Takahashi A, Majumdar A, Parameswaran H et al (2014) Proteoglycans maintain lung stability in an elastase-treated mouse model of emphysema. Am J Respir Cell Mol Biol 51:26–33CrossRefPubMedPubMedCentral Takahashi A, Majumdar A, Parameswaran H et al (2014) Proteoglycans maintain lung stability in an elastase-treated mouse model of emphysema. Am J Respir Cell Mol Biol 51:26–33CrossRefPubMedPubMedCentral
24.
go back to reference Cantor J, Armand G, Turino G (2015) Lung hyaluronan levels are decreased in alpha-1 antiprotease deficiency COPD. Respir Med 109:656–659CrossRefPubMed Cantor J, Armand G, Turino G (2015) Lung hyaluronan levels are decreased in alpha-1 antiprotease deficiency COPD. Respir Med 109:656–659CrossRefPubMed
25.
go back to reference Mižíková I, Ruiz-Camp J, Steenbock H et al (2015) Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia. Am J Physiol Lung Cell Mol Physiol 308:L1145–L1158CrossRefPubMed Mižíková I, Ruiz-Camp J, Steenbock H et al (2015) Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia. Am J Physiol Lung Cell Mol Physiol 308:L1145–L1158CrossRefPubMed
26.
go back to reference Counts DF, Evans JN, Dipetrillo TA et al (1981) Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. J Pharmacol Exp Ther 219:675–678PubMed Counts DF, Evans JN, Dipetrillo TA et al (1981) Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. J Pharmacol Exp Ther 219:675–678PubMed
27.
go back to reference Osman M, Kaldany RR, Cantor JO et al (1985) Stimulation of lung lysyl oxidase activity in hamsters with elastase-induced emphysema. Am Rev Respir Dis 131:169–170PubMed Osman M, Kaldany RR, Cantor JO et al (1985) Stimulation of lung lysyl oxidase activity in hamsters with elastase-induced emphysema. Am Rev Respir Dis 131:169–170PubMed
28.
go back to reference Doyle TJ, Pinto-Plata V, Morse D et al (2012) The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest J 142:1027–1034CrossRef Doyle TJ, Pinto-Plata V, Morse D et al (2012) The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest J 142:1027–1034CrossRef
29.
go back to reference Rosenberg SR, Kalhan R (2012) Biomarkers in chronic obstructive pulmonary disease. Transl Res 159:228–237CrossRefPubMed Rosenberg SR, Kalhan R (2012) Biomarkers in chronic obstructive pulmonary disease. Transl Res 159:228–237CrossRefPubMed
Metadata
Title
The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes
Authors
Xingjian Liu
Shuren Ma
Gerard Turino
Jerome Cantor
Publication date
01-02-2017
Publisher
Springer US
Published in
Lung / Issue 1/2017
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9956-2

Other articles of this Issue 1/2017

Lung 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.